Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain
about
sameAs
Clinical perspectives of TRAIL: insights into central nervous system disordersA computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer's as a case studyGene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.A Study of the Impact of Death Receptor 4 (DR4) Gene Polymorphisms in Alzheimer's Disease.TRAIL/TRAIL receptor system and susceptibility to multiple sclerosisApoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis?Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection.Cellular FLICE-inhibitory protein: an attractive therapeutic target?Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylationTRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ.Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ.Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.Apoptosis through Death Receptors in Temporal Lobe Epilepsy-Associated Hippocampal Sclerosis.Human brain astrocytes mediate TRAIL-mediated apoptosis after treatment with IFN-gamma.Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions.Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.Inflammation in the early stages of neurodegenerative pathologyOligodendrocyte-microglia cross-talk in the central nervous system.TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release.TRAIL limits excessive host immune responses in bacterial meningitis.Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice.Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy.
P2860
Q26766570-8E8CF5E4-7107-49B4-8719-320EE2DB2755Q28741856-C78E00C6-36E2-4128-BCDE-DC07859AAEE8Q33828114-49AA4A94-C611-4243-AF86-C26462D865FDQ33973867-78F67503-17B1-46D3-9FF6-BC77AD61126BQ33981373-9C796E4F-DA3F-478D-9E17-13FEB6A8FBE3Q34617250-8F443400-C8B2-4F50-A197-36AAC7F7EE37Q34808530-8C514041-45B7-4D9F-BE28-A1021B4F134CQ35186676-55C20A9B-AB48-4C99-8159-4E936C1D0BB9Q35741865-A2E326CB-B0E0-4A45-AFE7-3026149AE97EQ35842625-128BEA35-CA27-4ABC-8D6F-30D4F9A8E2BDQ36071985-57D4B9FE-FD03-4D8D-89D4-E2D9CBE94674Q36310187-336C8470-37D8-4E18-BCA6-610DA08EBE54Q36315249-E4F9EF99-6575-4359-A9B9-0740E39BAF4EQ36661383-B12BCA4C-DF76-4496-904F-DBABFB1D06DEQ37206824-98B4A06D-6500-4E7C-80CC-4DFA9CA1B0ABQ37258257-83D3F7F8-1E70-467B-86E8-3748435DFD8DQ37403279-008AC246-8E10-424C-9203-6852562C844DQ37912590-D0DCBEE5-75C9-486D-B1AD-F0C7D5B4278CQ38131845-6FC124EF-2298-4189-B73F-1EAC9955C931Q40608394-DDD06A4C-CE5E-41D6-B4EE-A8457D648060Q41837909-14AD7E18-8A8E-4785-8135-025027F063A3Q42682239-228F0836-885D-409B-BEBD-D855881D4C65Q47561992-891B9140-1DA0-456B-9B1F-24747AC39821Q50533963-F3FA3487-EBBF-4619-88E9-BD1AC7A75755
P2860
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lack of tumor necrosis factor- ...... s receptors in the human brain
@ast
Lack of tumor necrosis factor- ...... s receptors in the human brain
@en
Lack of tumor necrosis factor- ...... s receptors in the human brain
@nl
type
label
Lack of tumor necrosis factor- ...... s receptors in the human brain
@ast
Lack of tumor necrosis factor- ...... s receptors in the human brain
@en
Lack of tumor necrosis factor- ...... s receptors in the human brain
@nl
prefLabel
Lack of tumor necrosis factor- ...... s receptors in the human brain
@ast
Lack of tumor necrosis factor- ...... s receptors in the human brain
@en
Lack of tumor necrosis factor- ...... s receptors in the human brain
@nl
P2093
P1476
Lack of tumor necrosis factor- ...... s receptors in the human brain
@en
P2093
Henning Walczak
Ingo Bechmann
Orhan Aktas
Peter H Krammer
Robert Nitsch
P356
10.1523/JNEUROSCI.22-04-J0001.2002
P407
P577
2002-02-15T00:00:00Z